FDA 510(k)

XPER Technology PREMIUM Pro Blood Glucose Monitoring System

N.º K: K221349 · 2024-11-19

SolicitanteTaidoc Technology Corporation

Fecha de decisión2024-11-19

Código de productoPZI

Comité asesorCH

DecisiónSubstantially Equivalent

Resumen del dispositivo

XPER Technology PREMIUM Pro Blood Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Taidoc Technology Corporation. It received FDA 510(k) clearance on 2024-11-19 under 510(k) number K221349. The device is classified under product code PZI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the XPER Technology PREMIUM Pro Blood Glucose Monitoring System?

XPER Technology PREMIUM Pro Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2024-11-19. The listed applicant is Taidoc Technology Corporation. The 510(k) number is K221349.

When did XPER Technology PREMIUM Pro Blood Glucose Monitoring System receive FDA 510(k) clearance?

XPER Technology PREMIUM Pro Blood Glucose Monitoring System received FDA 510(k) clearance on 2024-11-19, under 510(k) number K221349.

Who is the listed applicant for XPER Technology PREMIUM Pro Blood Glucose Monitoring System?

The FDA 510(k) record lists Taidoc Technology Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for XPER Technology PREMIUM Pro Blood Glucose Monitoring System?

The FDA product code for XPER Technology PREMIUM Pro Blood Glucose Monitoring System is PZI.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Taidoc Technology Corporation como solicitante

K201037FORA ADVANCED GD40 Glucose, ß-Ketone and Cholesterol Monitoring System K200946Termómetro de frente Clever / Termómetro de frente médico Clever (Modelo TD-1241)K190579TD-4183 Blood Glucose Monitoring System K182934FORA P100 Blood Pressure Monitoring System K180863FORA NAS100 Electronic Nasal Aspirator, Electronic Nasal Aspirator K181675FORA MD6 Uric Acid Monitoring System, FORA MD6 Pro Uric Acid Monitoring System

Ver todos los 17 dispositivos →

Dispositivos relacionados (Código: PZI)

K252323cobas pulse blood glucose monitoring systemRoche Diagnostics K220272cobas pulse blood glucose monitoring systemRoche Diagnostics K232075StatStrip Glucose Hospital Meter SystemNova Biomedical Corporation K200788Assure Titanium Blood Glucose Monitoring SystemArkray, Inc.K182552StatStrip Xpress Glucose Hospital Meter SystemNova Biomedical Corporation K182549StatStrip Xpress 2 Glucose Hospital Meter SystemNova Biomedical Corporation

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.